Transcriptional regulation of interleukin 2 in SLE T cells
- PMID: 15204092
- DOI: 10.1080/08830180490452558
Transcriptional regulation of interleukin 2 in SLE T cells
Abstract
Interleukin-2 (IL-2) is a central cytokine required for the activation of T, B, and NK cells. It propagates the immune response and terminates it by promoting the activation induced cell death of T cells. IL-2 production is altered in T cells of patients with systemic lupus erythematosus (SLE). The consequence of reduced IL-2 production in SLE is decreased immune response to infectious agents. Decreased IL-2 production by SLE T cells is the result of transcriptional repression of the IL-2 gene. This article will review the defective transcription regulation of IL-2 in SLE T cells, which is the result of decreased expression of the enhancers NF-kappa B and AP1 and the increased expression of the transcriptional repressor CREM.
Similar articles
-
Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity.Clin Immunol. 2002 May;103(2):145-53. doi: 10.1006/clim.2002.5192. Clin Immunol. 2002. PMID: 12027419
-
Transcriptional repression of interleukin-2 in human systemic lupus erythematosus.Autoimmun Rev. 2006 Feb;5(2):118-21. doi: 10.1016/j.autrev.2005.08.009. Epub 2005 Sep 26. Autoimmun Rev. 2006. PMID: 16431340 Review.
-
Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.Arthritis Rheum. 2012 Nov;64(11):3715-25. doi: 10.1002/art.34596. Arthritis Rheum. 2012. PMID: 22736314
-
Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities.Autoimmun Rev. 2009 Sep;9(1):34-9. doi: 10.1016/j.autrev.2009.02.035. Epub 2009 Mar 6. Autoimmun Rev. 2009. PMID: 19269352 Review.
-
Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.J Rheumatol. 2007 Jan;34(1):89-96. Epub 2006 Nov 15. J Rheumatol. 2007. PMID: 17117487
Cited by
-
Dehydroepiandrosterone in systemic lupus erythematosus.Curr Rheumatol Rep. 2008 Aug;10(4):286-91. doi: 10.1007/s11926-008-0046-1. Curr Rheumatol Rep. 2008. PMID: 18662508 Free PMC article.
-
A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.J Biol Chem. 2011 Sep 16;286(37):32366-72. doi: 10.1074/jbc.M111.245811. Epub 2011 Jul 13. J Biol Chem. 2011. PMID: 21757709 Free PMC article.
-
IFN-β Selectively Inhibits IL-2 Production through CREM-Mediated Chromatin Remodeling.J Immunol. 2015 Jun 1;194(11):5120-8. doi: 10.4049/jimmunol.1403181. Epub 2015 Apr 17. J Immunol. 2015. PMID: 25888642 Free PMC article.
-
cAMP-responsive element modulator α (CREMα) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE).J Biol Chem. 2012 Dec 14;287(51):42525-32. doi: 10.1074/jbc.M112.425371. Epub 2012 Nov 2. J Biol Chem. 2012. PMID: 23124208 Free PMC article.
-
Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4+ T Cells-Implications for the Pathogenesis of Systemic Lupus Erythematosus.Int J Mol Sci. 2023 Jun 28;24(13):10749. doi: 10.3390/ijms241310749. Int J Mol Sci. 2023. PMID: 37445926 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical